Terns Pharmaceuticals, Inc. (TERN)
52.63
+0.07
(+0.13%)
USD |
NASDAQ |
Apr 10, 16:00
52.70
+0.07
(+0.13%)
After-Hours: 20:00
Terns Pharmaceuticals EPS Diluted (Quarterly) : -0.2395 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 1.191 |
| Corcept Therapeutics, Inc. | 0.1994 |
| Cogent Biosciences, Inc. | -0.6934 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| ADMA Biologics, Inc. | 0.2025 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.57M |
| Total Expenses (Quarterly) | 23.57M |
| Enterprise Value | 5.056B |
| Earnings Yield | -1.96% |
| Normalized Earnings Yield | -1.962 |